Skip to main content
. 2018 Dec 21;65(4):309–317. doi: 10.5606/tftrd.2019.3126

Table 3. Q-DASH, SF-36 and HADS scores of the groups.

  CB group (n=14) CB/SLD group (n=10)  
  Mean±SD Mean±SD p*
Q-DASH      
Pretreatment 54.4±20.2 55.7±16.2 0.868
At the end of the treatment 35.7±13.1 34.8±17.5 0.932
Six months after the treatment 27.7±9.5 28.6±9.7 0.831
p** <0.001 <0.001  
SF-36 PCS      
Pretreatment 39.6±7.4 33.7±11.0 0.127
At the end of the treatment 48.1±12.4 41.5±9.4 0.174
Six months after the treatment 57.9±15.2 63.9±17.6 0.380
p** 0.004 <0.001  
SF-36 MCS      
Pretreatment 52.2±11.8 55.8±10.9 0.934
At the end of the treatment 63.3±13.0 56.3±9.2 0.159
Six months after the treatment 68.1±11.3 70.6±14.9 0.653
p** 0.003 0.003  
HADS-A      
Pretreatment 6.1±4.7 4.9±3.4 0.486
At the end of the treatment 4.6±2.9 4.2±3.7 0.746
Six months after the treatment 4.7±2.1 3.4±2.4 0.741
p** 0.082 0.333  
HADS-D      
Pretreatment 4.1±3.5 4.9±4.6 0.625
At the end of the treatment 3.1±2.4 4.2±4.8 0.463
Six months after the treatment 1.9±1.8 2.0±1.5 0.841
p** 0.087 0.053  
Q-DASH: Quick Disabilities of Arm, Shoulder and Hand; SF-36: Short form-36; HADS: Hospital Anxiety and Depression Scale; CB: Compression bandage; SLD: Self lymphatic drainage; SD: Standard deviation; PCS: Physical Component Summary; MCS: Mental Component Summary; HADS-A: Hospital Anxiety and Depression Scale-Anxiety; HADS-D: Hospital Anxiety and Depression Scale- Depression; * Inter-group analysis, ** Intra-group analysis.